A detailed history of Taylor Wealth Management Partners transactions in Vyant Bio, Inc. stock. As of the latest transaction made, Taylor Wealth Management Partners holds 10,273 shares of VYNT stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,273
Previous 13,697 25.0%
Holding current value
$0
Previous $20,000 55.0%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.62 - $1.37 $2,122 - $4,690
-3,424 Reduced 25.0%
10,273 $9,000
Q1 2022

May 11, 2022

SELL
$0.99 - $1.61 $33,906 - $55,140
-34,249 Reduced 71.43%
13,697 $20,000
Q4 2021

Jan 28, 2022

SELL
$1.32 - $2.96 $45,211 - $101,382
-34,251 Reduced 41.67%
47,946 $65,000
Q3 2021

Oct 26, 2021

SELL
$2.26 - $3.74 $7,738 - $12,805
-3,424 Reduced 4.0%
82,197 $192,000
Q2 2021

Aug 11, 2021

BUY
$2.88 - $4.81 $246,588 - $411,837
85,621 New
85,621 $320,000

Others Institutions Holding VYNT

# of Institutions
2
Shares Held
213K
Call Options Held
0
Put Options Held
0

About Vyant Bio, Inc.


  • Ticker VYNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,343,200
  • Description
  • Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...
More about VYNT
Track This Portfolio

Track Taylor Wealth Management Partners Portfolio

Follow Taylor Wealth Management Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Wealth Management Partners with notifications on news.